CBD for back and spine pain: do oils or gummies help?
The only randomized study on CBD for lower back pain was on par with placebo. Check what the WHO guidelines recommend and which symptoms require urgent medical attention.
Lower back pain is the leading cause of disability worldwide, and few ailments have received as many empty promises (Hartvigsen i in., The Lancet, 2018). The number of years lived with disability due to this increased by 54 percent between 1990 and 2015, mainly due to population growth and aging. CBD is one of those promises. We checked in the European PMC database how many clinical studies actually stand behind the term "CBD oil for back pain." The result is clear: one randomized study with placebo assignment, conducted in an emergency department, where CBD performed equally to placebo. Therefore, you will not find dosage guidelines here. You will find what realistically changes the course of back pain and a list of symptoms for which you need to go to a doctor, not to a store.
KEY INFORMATION
• CBD was tested for lower back pain in one randomized study. The difference compared to placebo after two hours was 0.3 points on a scale of 0-10 against CBD (Bebee et al., Medical Journal of Australia, 2021).
• The WHO guidelines from 2023 did not formulate recommendations for cannabis products in chronic primary lower back pain.
• An acute episode of lower back pain usually significantly diminishes within the first six weeks (Wallwork et al., CMAJ, 2024).
• Disturbances in urination or defecation, perineal numbness, and increasing weakness of the leg are indications for urgent diagnostics.
Does CBD really work for back pain and spinal pain?
There is no evidence for that. The only randomized placebo-controlled study that tested CBD for lower back pain yielded a negative result. It is called CANBACK and involved one hundred patients in the emergency department in Melbourne with acute, non-traumatic lower back pain.
The study was randomized and double-blind, and the median age of participants was 47 years. Each received a single dose of 400 mg of cannabidiol or placebo, as an adjunct to standard pain medications used in the department. After two hours, the average pain intensity was 6.2 points on a scale from 0 to 10 in the CBD group (95% confidence interval 5.5 to 6.9) and 5.8 points in the placebo group (5.1 to 6.6). The absolute difference is 0.3 points against CBD, with a confidence interval from minus 1.3 to 0.6. The length of stay in the department and the use of oxycodone in the four hours before and after administration were similar in both groups. The authors' conclusion is straightforward: CBD did not prove to be better than placebo (Bebee i in., Medical Journal of Australia, 2021).
In the same issue of the journal, an editorial comment titled "Lack of efficacy of cannabidiol in alleviating back pain: time to reset expectations" was published (Hayes i Martin, 2021). Two years later, a literature review dedicated solely to this question summarized the state of knowledge similarly: there is a lack of evidence for the efficacy of CBD in acute lower back pain, there is one clinical study, and it did not show an advantage over placebo, and solid data require reliable randomized studies (Kulesza i in., Annals of Agricultural and Environmental Medicine, 2023).
What do current guidelines recommend for lower back pain?
Exercise, movement, and education, not cannabis preparations. In 2023, the WHO issued its first guidelines on non-surgical management of chronic primary low back pain in adults. They evaluated 37 non-surgical interventions that could be applied in primary healthcare, based on 367 randomized studies, and formulated 24 recommendations and one good practice statement.
Among the 19 evaluated medications, including cannabinoids and herbal preparations, only two were recommended for offering in most contexts: non-steroidal anti-inflammatory drugs and topically applied cayenne pepper. The recommendation for anti-inflammatory drugs does not include older adults. Cannabis preparations for medicinal purposes fell into the group of 12 interventions for which no recommendation was formulated, as the evidence was deemed inadequate or absent, or the balance of benefits and harms was ambiguous. Paracetamol and benzodiazepines were also included in this same group (Briggs i in., Global Health Research and Policy, 2025, discussion of the guidelines WHO).
| Group of medications assessed in the WHO 2023 guidelines | Resolution |
|---|---|
| Niesteroidowe leki przeciwzapalne | Recommended for offering, excluding older adults |
| Miejscowo stosowana papryka cayenne | Zalecana do oferowania |
| Cannabis products for therapeutic purposes | No recommendation, one of the 12 interventions without resolution |
| Paracetamol, benzodiazepiny | Brak zalecenia, ta sama grupa 12 |
| The remaining 19 evaluated medications | Were not among those recommended for offering |
On the side of non-pharmacological interventions, the picture is reversed. A review commissioned by the WHO showed that structured exercise programs likely reduce pain compared to no intervention (8 studies, standardized mean difference of minus 0.33, confidence interval from minus 0.58 to minus 0.08) and functional limitations (Verville i in., Journal of Occupational Rehabilitation, 2023). These are moderate certainty evidence, which is the strongest that exists on this topic.
What symptoms in back pain require urgent consultation?
Disturbances in urination or defecation, perineal numbness, and progressive weakness of the leg are signals of compression on the cauda equina roots. In this situation, time matters, not the product: urgent imaging and neurosurgical consultation are needed. This is the most important part of this article.
Symptoms for which one should not wait or experiment with supplementation:
- urinary or bowel disorders, including urinary retention and fecal incontinence
- numbness or tingling in the perineal area, buttocks, and inner thighs
- progressive weakness in the leg, foot drop, difficulty climbing stairs
- pain that occurred after an injury or fall, especially in a person over sixty or treated with glucocorticoids
- fever, chills, recent infection or procedure in the spinal area
- unintentional weight loss and a history of cancer
- night pain that does not subside at rest and wakes you from sleep
Cauda equina syndrome is rare but carries a high risk of permanent disability, and the therapeutic window is narrow. Early diagnosis, rapid imaging, and urgent decompression determine the return of neurological function (Aduri i in., Cureus, 2026). Two caveats. First, in almost all individuals with back pain, it is not possible to identify a specific nociceptive cause, and a well-understood pathology, such as a vertebral fracture, cancer, or infection, is present in a small percentage of patients (Hartvigsen et al., 2018). Second, the accuracy of individual alarm symptoms is limited. A Cochrane review encompassing 14 studies examined them for vertebral fractures and found that most of them, when used alone, do not perform well as a screening tool. A few proved useful, primarily older age, previous trauma, and the use of glucocorticoids, and their combinations worked better than single symptoms (Han i in., Cochrane Database of Systematic Reviews, 2023). Treat this list as a reason to contact a doctor, not as a tool for self-diagnosis.
How long does a typical episode of low back pain last?
Most episodes clearly diminish within the first six weeks. In a meta-analysis of 47 cohorts, the average pain intensity in the acute group dropped from 56 points out of 100 at the start to 26 after six weeks, 22 after six months, and 21 after one year (Wallwork i in., CMAJ, 2024).
In the subacute group, improvement stops earlier: from 63 points at the start to 29 after six weeks and 31 after one year. In the group with chronic pain, the change is minimal, from 56 to 40 points after one year, with very low certainty of evidence. The course of disability is somewhat more favorable than the course of pain itself.
This has direct implications for the assessment of supplements. If you start taking anything during the acute phase, improvement in the following weeks is what most people experience without any intervention. That’s why observational studies on CBD for back pain, conducted without a control group and without blinding, do not answer the question of efficacy. They show the passage of time, not the effect of the product.
Why do studies on cannabis for neuropathic pain say nothing about low back pain?
Because it is a different type of pain and most often a different substance. The material circulating under the slogan 'cannabis for pain' mostly comes from studies on THC-containing preparations conducted in neuropathic pain, which arises from damage to the nerve itself. Typical low back pain has a different mechanism.
When transferring these results to the back, three substitutions are made at once. The first concerns the substance: results obtained for THC extracts are attributed to CBD itself, even though these are two different compounds with different action profiles. The second concerns the diagnosis: data from neuropathic pain is transferred to overload pain in the lower back, where in almost all patients, a specific nociceptive cause cannot be identified. The third concerns the model: the anti-inflammatory effect described in rodents is presented as an argument that humans will stop having back pain. None of these transfers are justified, and combined they create the illusion of evidence that does not exist.
We described the difference between nociceptive and neuropathic pain more extensively in the post nociceptive pain vs. neuropathic pain. It is worth knowing this before reaching for any product advertised with the slogan "for pain." The authors of the review dedicated to CBD in back pain cautiously formulate the same: most of the ten included studies concern chronic pain, and the results suggest a benefit, but there is a lack of hard evidence, and rigorous randomized studies are needed (Kulesza i in., 2023). This cautious suggestion pertains to cannabinoids as a group, not to cannabidiol itself.
Oil or gummies for back pain, does the format make any difference?
Since the substance itself has not shown an advantage over placebo in low back pain, the question of format is secondary. The choice between oil and gummies changes the rate and predictability of absorption. It does not change whether CBD alleviates back pain.
It is also worth challenging the numbers that are repeated in almost every guide, including the earlier version of this text. A systematic review of CBD pharmacokinetics in humans included 24 studies and established that the only route of administration for which anyone measured absolute bioavailability is smoking: 31 percent. For sublingual and oral administration, no study provided such values. The half-life ranged from 1.4 to 10.9 hours after aerosol on the mucosa and from 2 to 5 days with chronic oral administration, and the maximum concentration increased after a meal and in fat-based formulations (Millar i in., Frontiers in Pharmacology, 2018). Popular comparisons like 'sublingual 20 to 35 percent, gummies 6 to 15 percent' have no basis in this data and have been removed from the article.
Real differences between formats are simpler. A gummy has a fixed content per piece, while oil allows for measuring less or more. A meal alters absorption. More on this in the texts CBD bioavailability and gummies vs. oil.
Why is there no dosage chart in this article?
Because there is no study from which it could be derived. The earlier version of this text provided a weekly breakdown with specific milligrams and number of drops. We removed it entirely because such numbers suggest precision that no one has measured in spinal pain.
The only dose tested in this diagnosis under randomization is a single 400 mg in the CANBACK study and did not outperform placebo. The ranges cited in guidelines come from studies on epilepsy, anxiety, or neuropathic pain, and are then manually scaled to back pain. A protocol written this way looks like a medical recommendation, but it is not.
There is also a second reason. CBD does not pass by other medications without effect, as it inhibits enzymes responsible for their metabolism. In an open crossover study on thirteen healthy volunteers, a single dose of 30 mg of CBD increased exposure to amitriptyline, a medication used for chronic pain, by about 13 percent in the area under the curve and 17 percent in maximum concentration. CBD did not significantly affect tramadol administered in the same scheme, and the authors caution that with longer use and in patients, the interaction may be stronger (Gorbenko i in., British Journal of Clinical Pharmacology, 2026). Therefore, the conversation about combining CBD with medications should be with a doctor or pharmacist and should concern your list of medications, not a table in an article.
Frequently Asked Questions
Does CBD help with back pain?
This has not been demonstrated. In the CANBACK study, one hundred patients with acute lower back pain received either CBD or placebo as an adjunct to standard treatment. After two hours, the average pain intensity was 6.2 points in the CBD group and 5.8 in the placebo group. The authors concluded that CBD was not better than placebo.
Does CBD help with sciatica?
There is no randomized study specifically testing CBD for sciatica. Data on cannabinoids in neuropathic pain pertains to products containing THC and other diagnoses. In cases of sciatica lasting more than six weeks or with increasing leg weakness, a medical consultation is needed, not a supplement.
How much CBD to take for back pain?
This cannot be responsibly stated. There is no study on lower back pain that has shown an effective dose of CBD, so any dosage in milligrams is transferred from studies on other conditions. If you are taking medications regularly, talk to your doctor or pharmacist about your list of medications.
Will a CBD ointment or cream work for the back?
Topical products do not have studies randomized for back pain. A substance applied to the skin of the back does not reach the nerve roots or the intervertebral disc. The relief felt may come from the act of rubbing itself and from the aromatic substances present in the formulation. More in the post ointment vs transdermal patch.
With lower back pain, is it better to lie down or move?
Move. Guidelines recommend education that supports self-management and a return to normal activity and exercise, and indicate excessive reliance on lying down, imaging, and opioids as a problem (Foster i in., The Lancet, 2018). Lying in bed is not a recommended treatment.
When does back pain require an urgent visit to the doctor?
When there are disturbances in urination or defecation, perineal numbness, progressive weakness of the limb, pain after an injury, fever, unintended weight loss, or night pain that does not subside at rest. These symptoms require urgent diagnostics, not trying another product.
If you still want to try, consider it a product that supports well-being, not a treatment for the spine. In the u Bucha store, you will find both hemp jellies, as well as hemp oils.
This article is for informational and educational purposes only and does not constitute medical advice. Before starting to use hemp or CBD for therapeutic purposes, consult your doctor, especially if you are taking other medications, are pregnant, or breastfeeding.
Author: Michał Waluk · Opublikowano: 2026-05-22 · Aktualizacja: 2026-08-15
